Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

OHI vs SBRA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

OHI Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

OHI Overall Winner 6-Pillar Tally: OHI 4 – 2 SBRA Matrix Metrics: OHI 7 – 3 SBRA

As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over Sabra Healthcare REIT, Inc. (SBRA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas SBRA carries 54.9/100 (HOLD) at $20.42 (28.2x Forward P/E, 18.4% operating margin).

  • Composite vs. Pillar Nuance: While SBRA currently prints a higher short-term Unified Composite Score (54.9/100 HOLD vs. OHI 50.5/100 HOLD), OHI captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (62.6% vs. 18.4% operating margin) and revenue trajectory (-0.6% vs. +31.6% YoY).
  • Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 54.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About OHI vs SBRA
OHI NYSE Head-to-Head Winner
Omega Healthcare Investors Inc.
Real Estate Investment Trusts
$46.91
-0.29% 1D
Market Cap $15.0B
TTM Revenue $1.26B
Forward P/E 22.6x
Beta / 30D Vol -0.04β · 29% Vol
Unified Composite Score
50.5 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 71.0 Mom 41.7
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope 0.5%) with fading momentum, RSI 50
RSI-14: 49.6 · SMA20: $47.08 · SMA50: $46.44
SBRA NASDAQ
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.42
-0.1% 1D
Market Cap $5.4B
TTM Revenue $924M
Forward P/E 28.2x
Beta / 30D Vol -0.01β · 31% Vol
Unified Composite Score
54.9 / 100 HOLD
Tech 42.0 Fund 50.0 Flow 74.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 54
RSI-14: 54.0 · SMA20: $20.17 · SMA50: $19.88

6-Pillar Scorecard Institutional Category Breakdown (OHI 4 – 2 SBRA)

Columns: Metric · OHI · SBRA
1. Valuation Multiples OHI
Forward P/E 22.6x 28.2x
Trailing P/E 19.0x 76.2x
PEG Ratio 11.99x 5.28x
EV / Revenue 14.9x 8.4x
2. Growth & Scale SBRA
Revenue Growth (YoY) -0.6% +31.6%
Earnings Growth (YoY) -55.4% +22.2%
TTM Revenue (USD) $1.26B $924M
Market Cap $15.0B $5.4B
3. Profitability & Quality OHI
Gross Margin 95.8% 49.6%
Operating Margin 62.6% 18.4%
Net Profit Margin 60.5% 7.7%
Return on Equity (ROE) 14.5% 2.5%
4. Balance Sheet & Cash Flow OHI
Cash Generation (TTM) $855M $401M
Cash Flow Margin 67.9% 43.3%
Net Cash / Leverage $3.83B Net Debt (0.73x D/E) $2.42B Net Debt (0.86x D/E)
Dividend Yield 5.61% 5.72%
5. Options & Positioning SBRA
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 26.9% (65th %ile) 21.6% (6th %ile)
Put/Call OI Skew 0.71x (Call-Skewed) 0.11x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Distribution DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat OHI
OpEx & R&D Intensity 33.2% of Rev ($418M) 31.2% of Rev ($288M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: OHI (7) vs SBRA (3)
Institutional Metric OHI SBRA Criterion Row Edge
Market Capitalization
Scale
$15.0B $5.4B Larger Scale OHI
Trailing P/E Ratio
Valuation
19.0x 76.2x Lower Multiple OHI
Forward P/E Ratio
Valuation
22.6x 28.2x Lower Multiple OHI
Revenue Growth (YoY)
Growth
-0.6% +31.6% Higher Growth SBRA
Operating Margin (TTM)
Profitability
62.6% 18.4% Higher Margin OHI
Net Profit Margin
Profitability
60.5% 7.7% Higher Margin OHI
Return on Equity (ROE)
Capital Efficiency
14.5% 2.5% Higher ROE OHI
52-Week Range Position
Momentum
46% ($42–$52) 55% ($18–$23) Stronger Trend SBRA
Beta / 30D Volatility
Risk Regime
-0.04β · 29% Vol -0.01β · 31% Vol Lower Realized Risk OHI
Unified Institutional Score
Composite Signal
50.5 / 100 (HOLD) 54.9 / 100 (HOLD) Higher Composite SBRA
Trailing 12M Revenue (USD)
Operating Scale
$1.26B $924M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
95.8% 49.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
11.99x PEG · 14.9x EV/Rev 5.28x PEG · 8.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$855M ($3.83B Net Debt (0.73x D/E)) $401M ($2.42B Net Debt (0.86x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBRA +2.79 pp
OHI: +2.79% · SBRA: +5.58%
3M Horizon OHI +0.58 pp
OHI: +1.02% · SBRA: +0.44%
6M Horizon SBRA +0.47 pp
OHI: -2.91% · SBRA: -2.44%
1Y Horizon SBRA +1.34 pp
OHI: +7.97% · SBRA: +9.31%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period OHI Revenue SBRA Revenue OHI Op. Margin SBRA Op. Margin Margin Leader
Q3 '25 $1.25B $760M 66.1% 31.3% OHI
Q4 '25 $1.28B $850M 63.2% 30.5% OHI
Q1 '26 $1.29B $890M 64.1% 30.8% OHI
Q2 '26 $1.31B $940M 58.9% -13.6% OHI
Q3 '26 $1.36B $1.00B 56.5% 25.6% OHI

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
OHI CONSOLIDATION
80d in phase · OBV DISTRIBUTION
Current IV 26.9%
IV Percentile 65th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact OHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SBRA CONSOLIDATION
79d in phase · OBV DISTRIBUTION
Current IV 21.6%
IV Percentile 6th %ile
Put/Call OI Skew 0.11x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SBRA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
OHI Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $15.0B market capitalization and 62.6% operating margin.
OpEx & R&D Reinvestment 33.2% of Rev ($418M)
90D Engineering Disclosures 0 Published
SBRA Moat Profile Scale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $5.4B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 31.2% of Rev ($288M)
90D Engineering Disclosures 0 Published

Investor FAQ OHI vs SBRA Key Questions & Quantitative Answers

As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over Sabra Healthcare REIT, Inc. (SBRA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas SBRA carries 54.9/100 (HOLD) at $20.42 (28.2x Forward P/E, 18.4% operating margin). Composite vs. Pillar Nuance: While SBRA currently prints a higher short-term Unified Composite Score (54.9/100 HOLD vs. OHI 50.5/100 HOLD), OHI captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (62.6% vs. 18.4% operating margin) and revenue trajectory (-0.6% vs. +31.6% YoY). Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 54.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SBRA leads the Growth & Scale pillar: OHI posts -0.6% YoY revenue growth and -55.4% YoY earnings growth on $1.26B TTM revenue (95.8% gross margin, 62.6% operating margin), compared with SBRA at +31.6% YoY revenue growth and +22.2% YoY earnings growth on $924M TTM revenue (49.6% gross margin, 18.4% operating margin). Across the 5-period historical trajectory (Q3 '25 to Q3 '26), OHI cumulative revenue shifted +8.8% while SBRA shifted +31.6%. In operating R&D and SG&A reinvestment, OHI deploys 33.2% of Rev ($418M) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($288M) (0 disclosures) for SBRA.

OHI screens cheaper on headline valuation multiples. OHI trades at 22.6x Forward P/E, 19.0x Trailing P/E, 11.99x PEG, and 14.9x EV/Revenue (67.9% FCF margin), whereas SBRA trades at 28.2x Forward P/E, 76.2x Trailing P/E, 5.28x PEG, and 8.4x EV/Revenue (43.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OHI (14.5% ROE) versus SBRA (2.5% ROE) capital efficiency.

In options market volatility and institutional positioning, OHI carries 26.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 29% Vol realized risk). By comparison, SBRA carries 21.6% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.01β · 31% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.